This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Denver Physician Breaks New Ground In Cochlear Implants

DENVER, Nov. 30, 2012 /PRNewswire/ -- A Swedish Medical Center ( www.SwedishHospital.com) physician is breaking new ground in the area of cochlear implants with his recent surgery on a 9-year-old girl who received the medical implant for single-sided deafness. Daniel Zeitler, M.D., a neurotologist and skull-based surgeon, is one of only a few medical professionals in the U.S. to perform the procedure for this population and diagnosis.

(Logo:  http://photos.prnewswire.com/prnh/20121130/PH21545LOGO-a )

(Photo:  http://photos.prnewswire.com/prnh/20121130/PH21545-b )

According to Zeitler, the young patient's deafness was beginning to take its toll on her both academically and socially.

"Although Claire is an excellent student, she had to sit strategically in the classroom to be able to hear. She often felt socially isolated during basketball practice or active family outings. Basically, all the things that a 9-year-old girl likes to do were slowly taken away because of her deafness," Zeitler says.

Young Claire received the cochlear implant on November 26. The MED-EL device will be activated on Dec. 18; however, Zeitler says early testing during surgery indicated it was working properly. The use of cochlear implants for single-sided deafness, and for patients as young as Claire, is an emerging practice in Europe, but is extremely rare in the U.S. In fact, the FDA has not yet approved the device for single-sided deafness, says Zeitler.

So why did Dr. Zeitler agree to this rare procedure? Because he feels Claire can benefit greatly from this technology, and he's confident the cochlear implant will dramatically improve the quality of life for this youngster sooner rather than later.

"There's a huge push to initiate clinical trials for its use in these circumstances in the U.S., but only a few anecdotal reports and small objective studies currently exist. Unfortunately, there is no good data or large-scale subjective experiences to make it the norm yet," Zeitler says.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,827.75 +12.81 0.07%
S&P 500 2,072.83 +5.80 0.28%
NASDAQ 4,787.3170 +29.0650 0.61%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs